Eton Pharmaceuticals, Inc. ETON Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $19.66M-24.2% | $25.94M-30.1% | $37.12M+46.3% | $25.38M+45.7% | $17.42M+16.6% | ||
| $13.41M+14.0% | $11.76M-10.1% | $13.08M-9.5% | $14.45M-11.9% | $16.4M+206% | ||
| $14.47M-6.2% | $15.42M-8.5% | $16.86M-29.2% | $23.79M+74.7% | $13.62M-10.6% | ||
| $53.25M-12.1% | $60.58M-15.9% | $72M+5.2% | $68.44M+37.0% | $49.96M+21.8% | ||
| $372K+14.1% | $326K+10.9% | $294K+1,533% | $18K-18.2% | $22K-35.3% | ||
| $43.74M+41.6% | $30.88M-3.1% | $31.88M-3.0% | $32.88M-3.0% | $33.88M-2.9% | ||
| $97.71M+6.1% | $92.11M-11.9% | $104.51M+2.8% | $101.68M+21.0% | $84.03M+10.4% | ||
| $13.49M+22.9% | $10.98M-23.0% | $14.26M+17.4% | $12.14M+149% | $4.87M+16.9% | ||
| $11.81M+34.3% | $8.79M+217% | $2.78M+0.3% | $2.77M— | —— | ||
| $44.18M+14.8% | $38.49M-12.9% | $44.18M+14.5% | $38.6M+52.3% | $25.35M+27.1% | ||
| $18.94M-13.0% | $21.77M-21.1% | $27.59M+0.7% | $27.41M-8.6% | $29.99M+0.6% | ||
| $67.1M+1.7% | $65.96M-19.0% | $81.38M+4.7% | $77.72M+30.4% | $59.58M+15.3% | ||
| $27K0.0% | $27K0.0% | $27K0.0% | $27K0.0% | $27K0.0% | ||
| -$110.94M+1.4% | -$112.49M+1.3% | -$113.98M-1.7% | -$112.05M-2.4% | -$109.47M-1.5% | ||
| $30.62M+17.1% | $26.15M+13.1% | $23.13M-3.5% | $23.96M-2.0% | $24.45M+0.1% | ||
| $97.71M+6.1% | $92.11M-11.9% | $104.51M+2.8% | $101.68M+21.0% | $84.03M+10.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Eton Pharmaceuticals, Inc.'s total assets?
- Eton Pharmaceuticals, Inc. (ETON) holds $97.7M in total assets, up 16.3% year over year.
- How much debt does Eton Pharmaceuticals, Inc. have?
- Eton Pharmaceuticals, Inc. carries $31.3M in total debt against $30.6M of shareholders' equity, a debt-to-equity ratio of 1.02.
- How much cash does Eton Pharmaceuticals, Inc. have?
- Eton Pharmaceuticals, Inc. holds $19.7M in cash and equivalents.
- Can Eton Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 1.21 — current assets exceed current liabilities.
- Where does Eton Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
